Medicare Enrolled
Dr. Scott Lunin, M.D.
Hematology · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lunin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lunin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lunin
Dr. Scott Lunin is a hematology in Sarasota, FL, with 20 years in practice. Based on federal Medicare data, Dr. Lunin performed 263,459 Medicare services across 5,021 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lunin received a total of $8,369 from 64 pharmaceutical and/or device companies across 536 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lunin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 11% volume in FL$ $8,369 industry payments
Medicare Practice Summary
Medicare Utilization ↗263,459
Medicare services
Top 11% in FL for hematology
5,021
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13,173 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 38,000 | $43 | $137 |
| Iron sucrose injection (Venofer) | 35,700 | $0 | $5 |
| Iron infusion (Feraheme) | 35,700 | $0 | $4 |
| Oxaliplatin chemotherapy injection | 24,060 | $0 | $12 |
| Anti-nausea injection (aprepitant) | 23,530 | $1 | $5 |
| Daratumumab injection (Darzalex) | 18,720 | $38 | $110 |
| Paclitaxel chemotherapy injection | 18,555 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 17,090 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 8,160 | $18 | $51 |
| Immune globulin infusion (Gammagard) | 7,780 | $36 | $108 |
| Dexamethasone injection (steroid) | 6,270 | $0 | $3 |
| Complete blood count (CBC) with differential | 3,538 | $8 | $29 |
| Blood draw (venipuncture) | 3,076 | $8 | $9 |
| Anti-nausea injection (ondansetron/Zofran) | 2,984 | $0 | $9 |
| Injection, atropine sulfate, 0.01 mg | 2,760 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,650 | $1 | $28 |
| Office visit, established patient (30-39 min) | 2,300 | $94 | $339 |
| Injection of additional new drug or substance into vein | 1,416 | $12 | $61 |
| Injection, leucovorin calcium, per 50 mg | 1,371 | $3 | $12 |
| Red blood count automated, with additional calculations | 1,030 | $5 | $20 |
| Drug injection, under skin or into muscle | 971 | $10 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 943 | $98 | $378 |
| Injection, fluorouracil, 500 mg | 654 | $2 | $7 |
| Injection, irinotecan, 20 mg | 601 | $2 | $177 |
| Office visit, established patient (20-29 min) | 538 | $69 | $239 |
| Injection, zoledronic acid, 1 mg | 431 | $7 | $69 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 418 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 394 | $22 | $84 |
| Injection, diphenhydramine hcl, up to 50 mg | 379 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 367 | $47 | $189 |
| Injection, carboplatin, 50 mg | 321 | $2 | $41 |
| Administration of chemotherapy into vein, each additional hour | 308 | $22 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 307 | $49 | $178 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 261 | $16 | $56 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 255 | $54 | $206 |
| Infusion into a vein for hydration, each additional hour | 201 | $10 | $42 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 173 | $3 | $11 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 151 | $15 | $59 |
| Infusion, normal saline solution , 1000 cc | 148 | $2 | $7 |
| Injection of drug or substance into vein | 140 | $27 | $156 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 131 | $26 | $89 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 117 | $124 | $637 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 98 | $15 | $56 |
| Prothrombin time test (blood clotting) | 90 | $4 | $15 |
| New patient office visit (45-59 min) | 90 | $116 | $453 |
| Automated urinalysis | 63 | $2 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 62 | $25 | $156 |
| Administration of additional new drug or substance into vein using push technique | 60 | $42 | $170 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 49 | $1 | $7 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 27 | $14 | $36 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 21 | $4 | $15 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.1% high complexity
78.6% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,369
Total received (2018-2024)
Avg $1,196/year across 7 years
Top 47% in FL for hematology
64
Companies
536
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,932 (94.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$414 (4.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,848
2023$2,467
2022$662
2021$23
2020$216
2019$1,459
2018$1,694
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$704
Janssen Biotech, Inc.
$673
Novartis Pharmaceuticals Corporation
$633
PFIZER INC.
$472
Genentech USA, Inc.
$470
BeiGene USA, Inc.
$464
Celgene Corporation
$412
Merck Sharp & Dohme Corporation
$394
Merck Sharp & Dohme LLC
$323
Gilead Sciences, Inc.
$323
Lilly USA, LLC
$286
AstraZeneca Pharmaceuticals LP
$279
Takeda Pharmaceuticals U.S.A., Inc.
$247
Daiichi Sankyo Inc.
$204
GlaxoSmithKline, LLC.
$199
GENZYME CORPORATION
$165
Rigel Pharmaceuticals, Inc.
$137
Astellas Pharma US Inc
$131
ARRAY BIOPHARMA INC
$120
Auris Health, Inc.
$117
Incyte Corporation
$112
AbbVie, Inc.
$97
ABBVIE INC.
$97
Amgen Inc.
$97
EMD Serono, Inc.
$91
Exelixis Inc.
$85
TAIHO ONCOLOGY, INC.
$84
Kite Pharma, Inc.
$64
PharmaEssentia USA Corporation
$62
Seagen Inc.
$61
Taiho Oncology, Inc.
$58
Pharmacyclics LLC, An AbbVie Company
$53
Dendreon Pharmaceuticals LLC
$48
JAZZ PHARMACEUTICALS INC.
$47
Regeneron Healthcare Solutions, Inc.
$40
MorphoSys, US Inc.
$36
Puma Biotechnology, Inc.
$35
ADC Therapeutics America, Inc.
$30
Bayer HealthCare Pharmaceuticals Inc.
$27
Heron Therapeutics, Inc.
$25
EUSA Pharma (US) LLC
$23
TerSera Therapeutics LLC
$22
Stemline Therapeutics Inc.
$22
Pharmacosmos Therapeutics Inc.
$20
Aveo Pharmaceuticals, Inc.
$18
AbbVie Inc.
$18
EISAI INC.
$18
Karyopharm Therapeutics Inc.
$17
AVEO Pharmaceuticals, Inc.
$17
Shire North American Group Inc
$16
Ipsen Biopharmaceuticals, Inc
$16
Array BioPharma Inc.
$16
Janssen Pharmaceuticals, Inc
$15
Alexion Pharmaceuticals, Inc.
$15
G1 Therapeutics, Inc.
$15
Horizon Pharma plc
$14
Mirati Therapeutics, Inc.
$14
Apellis Pharmaceuticals, Inc.
$13
Epizyme, Inc.,
$12
Jazz Pharmaceuticals Inc.
$12
Medtronic USA, Inc.
$11
Sirtex Medical Inc
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$9
Veracyte, Inc.
$5
Top 3 companies account for 24.0% of total payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Erleada · FOTIVDA · FRUZAQLA · GAUCHER-DISEASE · GAZYVA · IBRANCE · ICLUSIG · IMBRUVICA · INFLECTRA · INLYTA · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · RETACRIT · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · SYNCHROMED · Sylvant · TABRECTA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Venclexta · XALKORI · XOSPATA · XPOVIO · XTANDI · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
20
Per 100K population
4.5
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lunin is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lunin experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Lunin performed 38,000 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lunin receive payments from pharmaceutical companies?
Yes. Dr. Lunin received a total of $8,369 from 64 companies across 536 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lunin's costs compare to other hematologys in Sarasota?
Dr. Lunin's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lunin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Sarasota
Browse hematologys in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology